Folgen
Ivan V. Litvinov
Ivan V. Litvinov
McGill University Health Centre
Bestätigte E-Mail-Adresse bei mcgill.ca - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Is the Achilles’ heel for prostate cancer therapy a gain of function in androgen receptor signaling?
IV Litvinov, AM De Marzo, JT Isaacs
The Journal of Clinical Endocrinology & Metabolism 88 (7), 2972-2982, 2003
2882003
Low-calcium serum-free defined medium selects for growth of normal prostatic epithelial stem cells
IV Litvinov, DJ Vander Griend, Y Xu, L Antony, SL Dalrymple, JT Isaacs
Cancer research 66 (17), 8598-8607, 2006
1772006
Androgen receptor as a licensing factor for DNA replication in androgen-sensitive prostate cancer cells
IV Litvinov, DJ Vander Griend, L Antony, S Dalrymple, AM De Marzo, ...
Proceedings of the National Academy of Sciences 103 (41), 15085-15090, 2006
1462006
Malignant inflammation in cutaneous T‐cell lymphoma—a hostile takeover
T Krejsgaard, LM Lindahl, NP Mongan, MA Wasik, IV Litvinov, L Iversen, ...
Seminars in immunopathology 39, 269-282, 2017
1442017
Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progression
E Netchiporouk, IV Litvinov, L Moreau, M Gilbert, D Sasseville, M Duvic
Cell cycle 13 (21), 3331-3335, 2014
1402014
Iatrogenic epinephrine-induced reverse Takotsubo cardiomyopathy: direct evidence supporting the role of catecholamines in the pathophysiology of the “broken heart syndrome”
IV Litvinov, MA Kotowycz, S Wassmann
Clinical Research in Cardiology 98, 457-462, 2009
1322009
Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma
A Willerslev-Olsen, T Krejsgaard, LM Lindahl, IV Litvinov, S Fredholm, ...
Blood, The Journal of the American Society of Hematology 127 (10), 1287-1296, 2016
1192016
Cutaneous immune-related adverse events (irAEs) to immune checkpoint inhibitors: a dermatology perspective on management
A Muntyanu, E Netchiporouk, W Gerstein, R Gniadecki, IV Litvinov
Journal of Cutaneous Medicine and Surgery 25 (1), 59-76, 2021
1122021
PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor
IV Litvinov, L Antony, SL Dalrymple, R Becker, L Cheng, JT Isaacs
The Prostate 66 (12), 1329-1338, 2006
1082006
Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell lines
IV Litvinov, B Cordeiro, S Fredholm, N Ødum, H Zargham, Y Huang, ...
Cell cycle 13 (18), 2975-2982, 2014
1002014
Conversion of androgen receptor signaling from a growth suppressor in normal prostate epithelial cells to an oncogene in prostate cancer cells involves a gain of function in c …
DJ Vander Griend, IV Litvinov, JT Isaacs
International journal of biological sciences 10 (6), 627, 2014
992014
Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma
NA Sibbesen, KL Kopp, IV Litvinov, L Jønson, A Willerslev-Olsen, ...
Oncotarget 6 (24), 20555, 2015
972015
Elucidating the role of interleukin-17F in cutaneous T-cell lymphoma
T Krejsgaard, IV Litvinov, Y Wang, L Xia, A Willerslev-Olsen, SB Koralov, ...
Blood, The Journal of the American Society of Hematology 122 (6), 943-950, 2013
932013
Single-cell heterogeneity in Sézary syndrome
TB Buus, A Willerslev-Olsen, S Fredholm, E Blümel, C Nastasi, M Gluud, ...
Blood advances 2 (16), 2115-2126, 2018
862018
CD109 release from the cell surface in human keratinocytes regulates TGF‐β receptor expression, TGF‐β signalling and STAT3 activation: relevance to psoriasis
IV Litvinov, AA Bizet, Y Binamer, DA Jones, D Sasseville, A Philip
Experimental dermatology 20 (8), 627-632, 2011
832011
The use of transcriptional profiling to improve personalized diagnosis and management of cutaneous T-cell lymphoma (CTCL)
IV Litvinov, E Netchiporouk, B Cordeiro, MA Doré, L Moreau, K Pehr, ...
Clinical Cancer Research 21 (12), 2820-2829, 2015
822015
Artificial intelligence applications in dermatology: where do we stand?
A Gomolin, E Netchiporouk, R Gniadecki, IV Litvinov
Frontiers in medicine 7, 100, 2020
812020
Gene expression analysis in Cutaneous T-Cell Lymphomas (CTCL) highlights disease heterogeneity and potential diagnostic and prognostic indicators
IV Litvinov, MT Tetzlaff, P Thibault, P Gangar, L Moreau, AK Watters, ...
Oncoimmunology 6 (5), e1306618, 2017
802017
Comprehensive analysis of cutaneous T‐cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy
FM Ghazawi, E Netchiporouk, E Rahme, M Tsang, L Moreau, S Glassman, ...
Cancer 123 (18), 3550-3567, 2017
792017
Transcriptional profiles predict disease outcome in patients with cutaneous T-cell lymphoma
IV Litvinov, DA Jones, D Sasseville, TS Kupper
Clinical Cancer Research 16 (7), 2106-2114, 2010
792010
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20